Breaking News Instant updates and real-time market news.

IBM

IBM

$145.02

3.9 (2.76%)

09:23
10/17/18
10/17
09:23
10/17/18
09:23

IBM price target lowered to $164 from $172 at BMO Capital

BMO Capital analyst Keith Bachman lowered his price target on IBM to $164 and kept his Market Perform rating after its Q3 revenue miss, also lowering his expected FY19 revenue view to $78.9B from $79.7B on adverse FX. The analyst says he remains concerned with IBM being able to deliver "consistent performance" across its business portfolio after the latest quarter showed a 3% decline in Cognitive segment's software platforms and 8% decline in transaction processing. Bachman further contends that IBM is in a "competitive disadvantage" in application portfolio's commerce, talent, and marketing areas.

  • 21

    Oct

  • 22

    Oct

  • 03

    Mar

IBM IBM
$145.02

3.9 (2.76%)

10/17/18
MSCO
10/17/18
NO CHANGE
Target $168
MSCO
Overweight
IBM price target lowered to $168 after 'mixed' Q3 at Morgan Stanley
Morgan Stanley analyst Katy Huberty left her estimates on IBM unchanged after the company's "mixed" Q3, which featured Cognitive and Services signings that disappointed along with gross margins that stabilized earlier than expected. Huberty said IBM management was "surprisingly bullish" on its deal pipeline in Q4, but she thinks investors are likely to take a "wait and see" approach. While she views IBM as an underappreciated play on the "Data Era" and keeps an Overweight rating on the stock, Huberty lowered her price target on the shares to $168 from $185.
10/17/18
UBSW
10/17/18
NO CHANGE
Target $180
UBSW
Buy
IBM thesis working, shares should be bought, says UBS
UBS analyst John Roy noted IBM reported a decline in revenues in Q3, but he liked what he saw in margins and earnings. He thinks the stock could see some weakness from the revenue decline and if so, he would be a buyer of the share as the operational fixes will likely stay with the business units and the upside from bottoming revenue should start to work, particularly given the negative sentiment around the stock. Roy reiterated his Buy rating and $180 price target on IBM shares.
10/17/18
NOMU
10/17/18
NO CHANGE
Target $170
NOMU
Buy
IBM underlying sales trends 'remain healthy,' says Nomura Instinet
Nomura Instinet analyst Jeffrey Kvaal says that while IBM's "modest" Q3 sales miss is aggravated by weakness in growth engines cloud and analytics, he sees see signs that its underlying sales trends "remain healthy" and gross margins appear "sustainably stronger." Further, IBM is on track for its 2018 earnings and free cash flow goals, Kvaal tells investors in a post-earnings research note titled "A Step Sideways." The analyst keeps a Buy rating on the shares with a $170 price target.
10/17/18
CANT
10/17/18
NO CHANGE
Target $140
CANT
Neutral
IBM price target lowered to $140 from $152 at Cantor Fitzgerald
Cantor Fitzgerald analyst Joseph Foresi lowered his price target for IBM to $140 after the company's Q3 revenue fell short of expectations. A return to consistent organic growth and margin expansion are necessary for the stock to see sustainable multiple expansion from present levels, Foresi tells investors in a post-earnings research note. He notes IBM had flat constant currency growth in Q3. The analyst keeps a Neutral rating on the shares.

TODAY'S FREE FLY STORIES

CUBE

CubeSmart

$29.75

0.46 (1.57%)

07:57
11/15/18
11/15
07:57
11/15/18
07:57
Upgrade
CubeSmart rating change  »

CubeSmart upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GOOS

Canada Goose

$64.33

5.73 (9.78%)

07:56
11/15/18
11/15
07:56
11/15/18
07:56
Recommendations
Canada Goose analyst commentary  »

Canada Goose price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KREF

KKR Real Estate Finance

$20.56

-0.06 (-0.29%)

07:55
11/15/18
11/15
07:55
11/15/18
07:55
Syndicate
KKR Real Estate Finance 4.5M share Spot Secondary priced at $20.15 »

Morgan Stanley, Wells…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

LBTYA

Liberty Global

$24.27

0.6 (2.53%)

07:53
11/15/18
11/15
07:53
11/15/18
07:53
Periodicals
Liberty Global CFO says it is not desperate to divest UPC unit, Reuters reports »

Liberty Global is not…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

ALB

Albemarle

$99.95

0.72 (0.73%)

07:53
11/15/18
11/15
07:53
11/15/18
07:53
Initiation
Albemarle initiated  »

Albemarle initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

PRQR

ProQR Therapeutics

$17.82

-0.84 (-4.50%)

, ONCE

Spark Therapeutics

$40.93

-1.81 (-4.23%)

07:52
11/15/18
11/15
07:52
11/15/18
07:52
Initiation
ProQR Therapeutics, Spark Therapeutics initiated  »

ProQR Therapeutics…

PRQR

ProQR Therapeutics

$17.82

-0.84 (-4.50%)

ONCE

Spark Therapeutics

$40.93

-1.81 (-4.23%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

07:50
11/15/18
11/15
07:50
11/15/18
07:50
General news
U.S. retail sales preview: »

U.S. retail sales…

O

Realty Income

$63.17

0.32 (0.51%)

07:49
11/15/18
11/15
07:49
11/15/18
07:49
Upgrade
Realty Income rating change  »

Realty Income upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SRC

Spirit Realty

$8.04

-0.065 (-0.80%)

07:49
11/15/18
11/15
07:49
11/15/18
07:49
Downgrade
Spirit Realty rating change  »

Spirit Realty downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ECC

Eagle Point Credit

$17.34

-0.155 (-0.89%)

07:49
11/15/18
11/15
07:49
11/15/18
07:49
Downgrade
Eagle Point Credit rating change  »

Eagle Point Credit…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SAFE

Safety, Income and Growth

$18.97

(0.00%)

07:49
11/15/18
11/15
07:49
11/15/18
07:49
Downgrade
Safety, Income and Growth rating change  »

Safety, Income and Growth…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PCG

PG&E

$25.66

-7.04 (-21.53%)

07:49
11/15/18
11/15
07:49
11/15/18
07:49
Downgrade
PG&E rating change  »

Morgan Stanley cuts…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EPRT

Essential Properties Realty Trust

$13.96

-0.15 (-1.06%)

07:49
11/15/18
11/15
07:49
11/15/18
07:49
Downgrade
Essential Properties Realty Trust rating change  »

Essential Properties…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CSCO

Cisco

$44.35

-0.78 (-1.73%)

07:48
11/15/18
11/15
07:48
11/15/18
07:48
Recommendations
Cisco analyst commentary  »

Value investors should…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Nov

  • 10

    Jan

WLK

Westlake Chemical

$71.23

0.07 (0.10%)

07:48
11/15/18
11/15
07:48
11/15/18
07:48
Recommendations
Westlake Chemical analyst commentary  »

Westlake Chemical price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JEC

Jacobs Engineering

$73.26

-1.38 (-1.85%)

07:48
11/15/18
11/15
07:48
11/15/18
07:48
Hot Stocks
Jacobs Engineering selected by Waterbury city for wastewater utility operation »

Jacobs Engineering will…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Feb

JCP

J.C. Penney

$1.23

-0.05 (-3.91%)

07:47
11/15/18
11/15
07:47
11/15/18
07:47
Hot Stocks
Breaking Hot Stocks news story on J.C. Penney »

J.C. Penney drops 10.6%…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

EPZM

Epizyme

$7.27

-0.31 (-4.09%)

07:46
11/15/18
11/15
07:46
11/15/18
07:46
Conference/Events
Epizyme to host conference call »

Conference call to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Dec

CZR

Caesars

$8.16

0.02 (0.25%)

07:45
11/15/18
11/15
07:45
11/15/18
07:45
Initiation
Caesars initiated  »

Caesars initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

TSE

Trinseo

$46.28

1.3 (2.89%)

07:44
11/15/18
11/15
07:44
11/15/18
07:44
Upgrade
Trinseo rating change  »

Citi upgrades Trinseo to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MGM

MGM Resorts

$25.94

0.2 (0.78%)

07:43
11/15/18
11/15
07:43
11/15/18
07:43
Initiation
MGM Resorts initiated  »

MGM Resorts initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

  • 15

    Nov

  • 19

    Nov

MBRX

Moleculin Biotech

$1.29

-0.04 (-3.01%)

07:43
11/15/18
11/15
07:43
11/15/18
07:43
Hot Stocks
Moleculin Biotech files request with FDA for pre-IND meeting for WP1732 »

Moleculin Biotech…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LVS

Las Vegas Sands

$52.45

0.9 (1.75%)

07:42
11/15/18
11/15
07:42
11/15/18
07:42
Initiation
Las Vegas Sands initiated  »

Las Vegas Sands initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

APRN

Blue Apron

$1.17

-0.055 (-4.51%)

07:41
11/15/18
11/15
07:41
11/15/18
07:41
Recommendations
Blue Apron analyst commentary  »

Blue Apron price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

JCP

J.C. Penney

$1.23

-0.05 (-3.91%)

07:40
11/15/18
11/15
07:40
11/15/18
07:40
Hot Stocks
J.C. Penney sees FY18 comparable store sales down low-single digits »

Comparable store sales…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.